ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,90
0,25%
Bitcoin
94 761,08
-0,37%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Indivior PLC (INDV) Cours

Indivior PLC

Indivior PLC (INDV)

Indivior Plc
11,66
0,12
(1,04%)
Fermé 23 Décembre 10:00PM
Retardé de 15 minutes
11,66
-0,02
(-0,17%)
Après les heures de négociation: 12:20AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
11,66
Prix Achat
11,23
Prix Vente
11,66
Volume échangé
1 655 300
11,285 Fourchette du Jour 11,7797
7,33 Plage de 52 semaines 23,22
Cap du marché
1,511B
Clôture Veille
11,54
Ouverture
11,31
Dernière Transaction
636700
@
11.66
(priorref)
Dernière heure de transaction
Volume financier
US$ 19 182 257
VWAP
11,5884
Volume moyen (3 m)
1 274 848
Actions en circulation
129 575 205
Rendement du Dividende
-
Ratio Cours sur Bénéfices
596,10
Bénéfice par action (BPA)
0,02
Chiffre d'affairess
1,09B
Bénéfice net
2M

À propos de Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by... Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.indivior.com
Siège social
Berkshire, Gbr
Fondé
-
Indivior PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker INDV. Le dernier cours de clôture d'Indivior était de US$11,54. Au cours de la dernière année, les actions de Indivior ont été négociées dans une fourchette de prix de US$ 7,33 à US$ 23,22.

Indivior compte actuellement 129 575 205 actions en circulation. La capitalisation boursière d'Indivior est de US$1,50 milliard. Indivior a un ratio cours/bénéfice (ratio PE) de 596.10.

INDV Dernières nouvelles

Plus de nouvelles

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

18 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

03 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Novembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Novembre 2024
Edgar (US Regulatory)

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM...

19 Novembre 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.141.2152777777811.5212.199911.2809123252711.69049388CS
41.049.7928436911510.6212.199910.59124255311.43312045CS
121.7517.65893037349.9112.19997.3312748489.94672503CS
26-4.59-28.246153846216.2516.9757.33101493810.53539157CS
52-3.48-22.985468956415.1423.227.3356653911.30456804CS
156-14.84-5626.526.57.3337783811.43709408CS
260-14.84-5626.526.57.3337783811.43709408CS

INDV - Frequently Asked Questions (FAQ)

What is the current Indivior share price?
The current share price of Indivior is US$ 11,66
How many Indivior shares are in issue?
Indivior has 129 575 205 shares in issue
What is the market cap of Indivior?
The market capitalisation of Indivior is USD 1,5B
What is the 1 year trading range for Indivior share price?
Indivior has traded in the range of US$ 7,33 to US$ 23,22 during the past year
What is the PE ratio of Indivior?
The price to earnings ratio of Indivior is 596,1
What is the cash to sales ratio of Indivior?
The cash to sales ratio of Indivior is 1,09
What is the reporting currency for Indivior?
Indivior reports financial results in USD
What is the latest annual turnover for Indivior?
The latest annual turnover of Indivior is USD 1,09B
What is the latest annual profit for Indivior?
The latest annual profit of Indivior is USD 2M
What is the registered address of Indivior?
The registered address for Indivior is 234 BATH ROAD, SLOUGH, BERKSHIRE, SL1 4EE
What is the Indivior website address?
The website address for Indivior is www.indivior.com
Which industry sector does Indivior operate in?
Indivior operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
INDV
Indivior
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés